Bryan Shaw, Ph.D.

Dr. Shaw is assistant professor of chemistry and biochemistry. His research focuses on protein misfolding, which is believed to be the fundamental cause of several human diseases, including type 2 diabetes, cataracts, and many neurodegenerative diseases such as Alzheimer’s and amyotrophic lateral sclerosis (ALS).

He is also collaborating with researchers at Massachusetts Hospital and Dana Farber Cancer Institute to develop a better method to detect and diagnose retinoblastoma in infants. Early detection leads to a higher rate of survival and vision preservation for this potentially fatal disease.

Shaw received his Ph.D. in inorganic chemistry from UCLA and completed a post-doctoral fellowship at Harvard University.